mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.5 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.5 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |